Top

Clinical and Translational Allergy

Published in:

Open Access 01-12-2018 | Research

The kinase LRRK2 is differently expressed in chronic rhinosinusitis with and without nasal polyps

Authors: Yue Ma, Chunquan Zheng, Le Shi

Published in: Clinical and Translational Allergy | Issue 1/2018

Abstract

Background

Chronic rhinosinusitis (CRS), commonly divided into CRS with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP) is an inflammatory disease which mechanism remain unclear. Leucine-rich repeat kinase 2 (LRRK2) has been proved to be a negative regulator of inflammation response while its role in pathogenesis of CRS has yet to be revealed. This research study was designed to investigate the relationship between the expression level and biologic role of LRRK2 in CRS.

Methods

Expression of LRRK2 mRNA and noncoding repressor of NFAT (NRON) were examined by qRT-PCR. Protein levels of LRRK2 were performed by western blot and immunohistochemistry. Nuclear factor of activated T cells (NFAT) nuclear translocation was analyzed by immunohistochemistry. Additionally, LRRK2 mRNA and NRON expression in response to specific inflammatory stimulation was measured in human nasal epithelia cells (HNECs).

Results

The expression of LRRK2 was increased in CRSsNP patients (p < 0.05) and positively correlated with the expression levels of CD3 and Charot-Leyden crystal. Meanwhile, the NRON expression level is much lower in CRSsNP patients compared to both the control group and CRSwNP group (p < 0.05). Marked enhanced NFAT nuclear localization was observed in CRSwNP groups compared with the CRSsNP and control group (p < 0.0001). And the over-expression of LRRK2 was significantly regulated by lipopolysaccharide (LPS) in HNECs (p < 0.05). Moreover, IL-17A can increase LRRK2 expression and suppress NRON expression in vitro and dexamethasone can rescue the NRON inhibition.

Conclusion

LRRK2 and NRON may play different role in CRSsNP and CRSwNP. The molecular mechanisms identified here may aid in the design of novel therapeutic strategies to improve clinical outcomes.

Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015;136:1442–53. https://doi.org/10.1016/j.jaci.2015.10.009.CrossRefPubMedPubMedCentral

Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–9. https://doi.org/10.1111/j.1398-9995.2006.01225.x.CrossRefPubMed

Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, Cuvelier C, Van Cauwenberge P, Bachert C. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol. 2009;124:253–9. https://doi.org/10.1016/j.jaci.2009.04.013.CrossRefPubMed

Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi-Peters A, Grammer LC, Schleimer RP. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol. 2008;22:549–59. https://doi.org/10.2500/ajr.2008.22.3228.CrossRefPubMedPubMedCentral

Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. 2004;44:595–600. https://doi.org/10.1016/j.neuron.2004.10.023.CrossRefPubMed

Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601–7. https://doi.org/10.1016/j.neuron.2004.11.005.CrossRefPubMed

Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci. 2005;30:151–9. https://doi.org/10.1016/j.tibs.2005.01.003.CrossRefPubMed

Russo I, Bubacco L, Greggio E. LRRK2 and neuroinflammation: Partners in crime in Parkinson’s disease? J Neuroinflamm. 2014;11:52. https://doi.org/10.1186/1742-2094-11-52.CrossRef

Dzamko N, Halliday GM. An emerging role for LRRK2 in the immune system. Biochem Soc Trans. 2012;40:1134–9. https://doi.org/10.1042/bst20120119.CrossRefPubMed

10.

Mamais A, Cookson MR. LRRK2: dropping (kinase) inhibitions and seeking an (immune) response. J Neurochem. 2014;129:895–7. https://doi.org/10.1111/jnc.12691.CrossRefPubMedPubMedCentral

11.

Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010;185:5577–85. https://doi.org/10.4049/jimmunol.1000548.CrossRefPubMedPubMedCentral

12.

Kuss M, Adamopoulou E, Kahle PJ. Interferon-gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages. J Neurochem. 2014;129:980–7. https://doi.org/10.1111/jnc.12668.CrossRefPubMed

13.

Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza-Blanc P, Hogenesch JB, Schultz PG. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science. 2005;309:1570–3. https://doi.org/10.1126/science.1115901.CrossRefPubMed

14.

Liu Z, Lee J, Krummey S, Lu W, Cai H, Lenardo MJ. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol. 2011;12:1063–70. https://doi.org/10.1038/ni.2113.CrossRefPubMedPubMedCentral

15.

Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Kumar KA, Kramper M, Orlandi RR, Palmer JN, Patel ZM, Peters A, Walsh SA, Corrigan MD. Clinical practice guideline (update): adult sinusitis executive summary. Otolaryngol Head Neck Surg. 2015;152:598–609. https://doi.org/10.1177/0194599815574247.CrossRefPubMed

16.

Wang H, Bai J, Ding M, Liu W, Xu R, Zhang J, Shi J, Li H. Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2013;270:1867–72. https://doi.org/10.1007/s00405-012-2295-x.CrossRefPubMed

17.

Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50:1–12. https://doi.org/10.4193/Rhino50E2.PubMed

18.

Liu Z, Lenardo MJ. The role of LRRK2 in inflammatory bowel disease. Cell Res. 2012;22:1092–4. https://doi.org/10.1038/cr.2012.42.CrossRefPubMedPubMedCentral

19.

Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol. 2009;124:37–42. https://doi.org/10.1016/j.jaci.2009.04.045.CrossRefPubMedPubMedCentral

20.

Hakimi M, Selvanantham T, Swinton E, Padmore RF, Tong Y, Kabbach G, Venderova K, Girardin SE, Bulman DE, Scherzer CR, LaVoie MJ, Gris D, Park DS, et al. Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm (Vienna). 2011;118:795–808. https://doi.org/10.1007/s00702-011-0653-2.CrossRef

Title: The kinase LRRK2 is differently expressed in chronic rhinosinusitis with and without nasal polyps
Authors: Yue Ma
Chunquan Zheng
Le Shi
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Clinical and Translational Allergy / Issue 1/2018
Electronic ISSN: 2045-7022
DOI: https://doi.org/10.1186/s13601-018-0194-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The kinase LRRK2 is differently expressed in chronic rhinosinusitis with and without nasal polyps

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

On-demand intermittent beclomethasone is effective for mild asthma in Brazil

Assessing severity of anaphylaxis: a data-driven comparison of 23 instruments

Airborne protein concentration: a key metric for type 1 allergy risk assessment—in home measurement challenges and considerations

Relationship between vitamin D and chronic spontaneous urticaria: a systematic review

Insulin allergy can be successfully managed by a systematic approach

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence